Milestone Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.40
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.41
|
-0.34
|
0.07
|
17.07%
|
|
2022-06-30
|
-0.36
|
-0.39
|
-0.03
|
-8.33%
|
|
2022-03-31
|
-0.39
|
-0.33
|
0.06
|
15.38%
|
|
2021-12-31
|
-0.36
|
-0.40
|
-0.04
|
-11.11%
|
|
2021-09-30
|
-0.38
|
-0.34
|
0.04
|
10.53%
|
|
2021-06-30
|
-0.26
|
0.02
|
0.28
|
107.69%
|
|
2021-03-31
|
-0.33
|
-0.30
|
0.03
|
9.09%
|
|
2020-12-31
|
-0.41
|
-0.13
|
0.28
|
68.29%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.06
|
|
2021-12-31
|
-1.02
|
|
2020-12-31
|
-1.73
|
|
2019-12-31
|
-2.60
|